1. Mycophenolic acid, an antibiotic of some antiquity that more recently has been found to have marked activity against a range of tumours in mice and rats, strongly inhibits DNA synthesis in the L strain of fibroblasts in vitro. 2. The extent of the inhibition of DNA synthesis is markedly increased by preincubation of the cells with mycophenolic acid before the addition of [14C]thymidine. 3. The inhibition of DNA synthesis by mycophenolic acid in L cells in vitro is reversed by guanine in a non-competitive manner, but not by-hypoxanthine, xanthine or adenine. 4. The reversal of inhibition by guanine can be suppressed by hypoxanthine, 6-mercaptopurine and adenine. Mycophenolic acid (I) has been found in these laboratories (Carter, 1966; Carter et at. 1969) , and also independently by Williams et al. ( 1968) , to have marked activity against a range of experimental tumours in rats and mice. In view of the potential importance of these findings an investigation into the biochemical activity of mycophenolic acid has been carried out. Gosio (1896) was apparently the first to isolate mycophenolic acid from a Penicillium culture. This work was confirmed by Alsberg & Black (1913) , who gave the substance its name. Structural studies were carried out by Raistrick and his co-workers, culminating in the publication of the structure illustrated in (I) (Birkinshaw, Raistrick & Ross, 1952) . Mycophenolic acid was found to have limited antibacterial and antifungal activity by a number of workers including Abraham (1945) , Florey, Gilliver & Jennings (1946) and Gilliver (1946) .
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mycophenolic acid has a potent antimitotic effect against mammalian cells and that it is an effective antitumour agent (Carter, 1966) led us to make a study of the biochemical activity of the antibiotic on mammalian cells. Mycophenolic acid is shown to be a potent inhibitor ofnucleic acid synthesis largely by its ability to inhibit the enzyme IMP dehydrogenase (IMP-NAD oxidoreductase, EC 1.2.1.14) (Franklin, 1968) . A preliminary account of this work has been given (Carter et al. 1969) . Cells.
(1) L strain mouse fibroblasts were grown on gla#s in Eagle's medium (Parker, 1961) supplemented with 8% (v/v) filtered calf serum (Eagle's growth medium). These cells were used in the exponential phase of growth for the study of the effects of mycophenolic acid. The medium covering the cells (1 ml.) was replaced with fresh medium containing various additives (see the Results section) immediately before the start of an experiment.
(2) LS strain fibroblasts were supplied to us by the Microbiological Research Establishment, Porton Down, Wilts.
(3) Ascites cells. Landschutz and Yoshida ascites-tumour cells were obtained respectively from white mice 7-10 days, and from albino rats 5-6 days, after inoculation of the tumours. Either the cells were immediately sedimented at 600g for 5rmin. at 0-1' and then resuspended in one of the buffers described in the Results section or the ascitic fluid was diluted directly with one of these buffers. To obtain the most reproducible results it was necessary to start the incubations within 20min. of the removal of the tumour cells from the animals.
Uptake of radioactive precur8ors. The uptake of labelled precursors into the nucleic acid of cells in vitro was determined as described by Franklin & Higginson (1967) . The distribution of [14C] adenine between the RNA and DNA of L cells was determined by incubating the filter-paper strips impregnated with washed precipitated protein and nucleic acid in a medium containing 50mm-tris-HCl buffer, pH7-2, SmM-MgCl2 and 20 tzg. of either ribonuclease or deoxyribonuclease/ml. After incubation for 1 hr. the strips were washed successively in ice-cold 5% (w/v) trichloroacetic acid, ethanol-diethyl ether (3:1, v/v) and finally diethyl ether. The strips were dried and the radioactivity was measured as described by Franklin (1963) .
In experiments where the uptake oflabelled hypoxanthine into purine bases was studied, the acid-soluble and -insoluble nucleotides were isolated as follows. When intact cells were used the cells were washed by suspension and centrifugation in ice-cold 0-14M-NaCl solution. The cell pellet was then extracted with 5% (w/v) trichloroacetic acid at 00 for 30min. followed by centrifugation at 100OOg for 10min. The pellet was washed with ice-cold 5% (w/v) trichloroacetic acid and centrifuged and the supernatant fractions were combined (acid-soluble fraction). The pellet was then extracted with 5% (w/v) trichloroacetic acid at 90°for 5min. to hydrolyse the nucleic acids. After centrifugation the pellet was washed with 5% (w/v) trichloroacetic acid and the supernatant fractions were combined (acidinsoluble fraction). Both acid-soluble and -insoluble fractions were extracted three times with diethyl ether to remove trichloroacetic acid. After the aqueous layers had been evaporated to dryness the residues were dissolved in 2M-HCl, and the solutions were sealed in hard-glass tubes and heated at 1000 for 60min. The purine bases were then separated by high-voltage electrophoresis on Whatman no. 1 paper in a medium containing equal volumes of 1-5M-formic acid and 2m-acetic acid, pH2-0. After electrophoresis for 30-45min. at 6kv, the sheets were dried and the areas corresponding to purine marker spots were cut out and the radioactivity was measured as described by Franklin (1963) .
In experiments involving cell-free preparations the reaction was terminated with an equal volume of ice-cold 10% (w/v) trichloroacetic acid. After centrifugation the purine bases in the supernatant were isolated as described above.
The incorporation of [14C]formate into FGAR* was determined as follows. After incubation with the labelled precursor as described in the Results section, the cells were separated by centrifugation and washed by resuspension in ice-cold 0-14M-NaCl solution. The cell pellet was then extracted at 00 with 0-2M-HClO4 and centrifuged. The supernatant fraction was neutralized with 1M-NaHCO3. FGAR was isolated from the neutral supernatant by using a column (3cm. x 1cm.) of Dowex 1 (formate form) as described by Henderson (1962) . The authenticity of the FGAR isolated by this procedure was checked by using the ion-exchange method of Moore & LePage (1957) . The FGAR fraction was evaporated to dryness and then redissolved in water. This solution (2-5 ml.) was mixed with the scintillator solution (17-5ml.) described by Scales (1967) With ascites cells, erythrocytes were first removed as described above. The cells were treated in the ultrasonic oscillator for 20sec. and then centrifuged at 210OOg for 30 min. The supernatant fraction was mixed with protamine sulphate solution as described above. After 10min. at 2°, the precipitate was removed by centrifugation and discarded. The supernatant was adjusted to 25% saturation with (NH4)2SO4 and the precipitate removed by centrifugation. The fraction precipitated between 25% and 45% saturation with (NH4)2SO4 was dissolved in 15 mMpotassium phosphate buffer, pH 7.4 (final concn., 5mg. of protein/ml.). Most of the IMP dehydrogenase activity was again found in this fraction, which was stored at -20°. Usually a small amount ofprecipitate was found on thawing and this was removed by centrifugation and discarded. The xanthine oxidase activity of IMP dehydrogenase preparations from Landschutz ascites cells and LS cells was negligible. IMP dehydrogenase activity was assayed by the method of Atkinson, Morton & Murray (1963) .
Determination ofnucleic acids. Nucleic acid was extracted from cells with 0-5M-HC1O4 at 70°. The DNA was determined by the method of Burton (1956) and RNA by the method of Ceriotti (1955) .
Determination of protein. in the absence of mycophenolic acid was linear for at least 6hr. Fig. 1 shows that the antibiotic markedly inhibited DNA synthesis. A lag that was observed before the inhibitory effect of mycophenolic acid appeared decreased as the concentration of the antibiotic was increased. However, even at a concentration of mycophenolic acid as low as 0-1 ,ug./ml. DNA synthesis ceased after 4 hr. incubation with the drug.
The results of preincubation of the cells with mycophenolic acid before the addition of [14C]-thymidine are shown in Fig. 2 . After preincubation with lO,ug. of antibiotic/ml., the label was added and incubation continued for 2hr. The inhibition of DNA synthesis by mycophenolic acid was markedly increased by preincubation.
To determine the effect of mycophenolic acid on RNA synthesis, L cells were preincubated for 1 hr. with or without 10,ug. of mycophenolic acid/ml.
[14C]Adenine (0-1 uc/ml.) was then added and incubation continued for 2hr. The distribution of the radioactivity between RNA and DNA was then determined as described in the Materials and Methods section. The Table 4 . Effects of purine compounds on the reversal of mycophenolic acid-induced inhibition of DNA synthesis by guanine in L cells
The cells (in 1ml. of medium/tube) were preincubated with the indicated additions for 1 hr.
[14C]Thymidine (0-1 ,uc/ml.) was then added and the incubation continued for 2 hr., after which the uptake of radioactivity into coldacid-insoluble material was measured as described in the Materials and Methods section. The concentration of mycophenolic acid was 10,g./ml.
Additions to cells Mycophenolic acid Mycophenolic acid+guanine (1 g./ml.) Mycophenolic acid+guanine (1 g./ml.)+ hypoxanthine (10tg./ml.) Mycophenolic acid+guanine (10,ug./ml.)+ hypoxanthine (10jig./ml.) Mycophenolic acid+guanine (1 itg./ml.) + 6-mercaptopurine (10,ug./ml.)
Mycophenolic acid+guanine (10jg./ml.)+ 6-mercaptopurine (0l,g./ml.) Mycophenolic acid+ guanine (1 ,ug./ml.) + adenine (10,g./ml.) Mycophenolic acid+guanine (10,g./ml.)+ adenine (1lOjg./ml.) Mycophenolic acid+guanine (1 ,tg./ml.) + xanthine (10lpg./ml.) Hypoxanthine (10tg./ml. adenine, hypoxanthine and xanthine had no effect. Guanine, adenine and hypoxanthine were all readily incorporated into the nucleic acids of L cells in the absence of mycophenolic acid. The action of guanine in reversing the inhibition cauised by mycophenolic acid was apparently not a competitive effect, since Table 3 shows that, when the minimum effective concentration of guanine was used, it was not possible to overcome its reversal of mycophenolic acid inhibition with ten times the usual inhibitory concentration of mycophenolic acid.
Guanine is directly converted into its corresponding ribonucleotide by the enzyme hypoxanthineguanine phosphoribosyltransferase, i.e. IMP-pyrophosphate phosphoribosyltransferase (EC 2.4.2.8). This conversion is competitively inhibited by hypoxanthine and by 6-mercaptopurine, which are also substrates for the enzyme (Atkinson & Murray, 1965) . Thus it was considered that these two substances might prevent the reversal by guanine of the inhibition of DNA synthesis by mycophenolic acid if the action of guanine depended on its prior conversion into GMP. The effects of hypoxanthine and 6-mercaptopurine are shown in Table 4 . Although the action of 6-mereaptopurine may be questionable because of the intrinsic inhibitory action of this compound on DNA synthesis, the action of hypoxanthine in suppressing the reversal by guanine is particularly striking, since hypoxanthine itselfdid not inhibit DNA synthesis. When Vol. 11.3 519I T. J. FRANKLIN AND J. M. COOK1 the ratio of guanine to hypoxanthine or of guanine to 6-mercaptopurine was increased from 041 to 10, the reversal of the inhibition by mycophenolic acid was restored. Adenine, which is not a substrate for hypoxanthine-guanine phosphoribosyltransferase (Atkinson & Murray, 1965) , rather surprisingly suppressed the reversal by guanine. In this case an increase in the guanine/adenine ratio from 0-1 to 1 0 was much less effective in restoring the reversing action of guanine. Xanthine did not suppress the reversing effect of guanine on the inhibition by mycophenolic acid.
The effects of the various purines on the inhibition of DNA synthesis in L cells by mycophenolic acid strongly suggested that the effect of the antibiotic was due to an interruption in the supply of guanine nucleotides. The failure of hypoxanthine to reverse the action of mycophenolic acid, despite the fact that hypoxanthine is readily converted into guanine nucleotides in the absence of the antibiotic (see below), indicated that the site of inhibition by mycophenolic acid lay in the two-step conversion of IMP to GMP via XMP. More direct evidence for this possibility was therefore sought.
Effect of mycophenolic acid on the incorporation of [l4C]hypoxanthine into the purine nucleotides of mammalian cells in vitro.
(1) Landschutz and Yoshida ascites cells. The ascitic fluid was diluted to 107 cells/ml. with Ca2+-free Krebs-Ringer phosphate medium, pH7-4, containing 5*5mm-glucose, 1mM-glutamine and 2-3mM-glycine. The cell suspension (8ml.) was preincubated at 370 with or without 50,tg. of mycophenolic acid/ml. for 30min. followed by the addition of 0-06,uc of [14C]hypoxanthine/ml. for 1 hr. At the end of this period the distribution of radioactivity among cold-acid-soluble and -insoluble fractions of the cells was determined as described in the Materials and Methods section. The results in Table 5 show that mycophenolic acid strongly inhibited the conversion of hypoxanthine into the guanine of the acid-soluble and -insoluble fractions of both types of ascites cell. It is worth noting that there was some increase in the total radioactivity of the acid-soluble adenine fractions in the presence of mycophenolic acid, although specific-radioactivity measurements were not possible.
(2) L cells were grown in flat-sided bottles for this experiment (approx. 6 x 107 cells/bottle). The medium in each bottle was replaced by 40ml. of fresh Eagle's growth medium at 370 with or without 10tg. of mycophenolic acid/ml. and the bottles were incubated for 1 hr. After the addition to each bottle of 4,uc of [14C]hypoxanthine the incubation was continued for 2hr. The incorporation of label into cold-acid-soluble and -insoluble fractions was then determined. Table 5 shows that mycophenolic acid produced a striking decrease in the radioactivity of the acid-soluble guanine fraction. As expected from the inhibitory action ofmycophenolic acid on nucleic acid synthesis in L cells, the radioactivity of both adenine and guanine of the acidinsoluble fraction was lower in the antibiotictreated cells, although the decline in the radioactivity of the guanine fraction was the most marked.
Effect of mycophenolic acid on the fate of [14C]-hypoxanthine in an ultrasonic extractfrom Landschiitz ascites cells. In the presence of the appropriate cofactors, crude cell-free extracts from ascites cells Guanine  19500  240  11200  900  44000  10380   Adenine  37600  76800  80000  91000  135000  157000   Guanine  23100  2000  8450  640  176000  10290   Adenine  14890  18800  14210  14400   109000   57000 r,,2n 1969 Table 6 . Effect of mycophenolic acid on the fate of
[l4C]hypoxanthine in a cell-free extract frotn
Landschutz ascites cells
An ultrasonic extract prepared from Landschutz ascites cells as described in the Materials and Methods section was incubated at 370 for 15min. in the following reaction mixture: extract (0.5ml., 6mg. of protein), 27mM-ATP, 42mM-NAD+, 10mM-glutamine, 82mM-phosphoenolpyruvate, 270mM-nicotinamide, 140mm-ribose 5-phosphate, 0-1 mM-[14C]hypoxanthine, 12 -5mM-tris-HCl buffer, pH7-8, 2-5 mM-MgCI2; total volume 1 ml. The concentration of mycophenolic acid was 50/4g./ml. convert hypoxanthine into IMP, AMP, XMP and GMP (Shigeura & Gordon, 1962; Atkinson et al. 1963) . The effect of mycophenolic acid on the conversion of [14C]hypoxanthine into xanthine and guanine nucleotides by an ultrasonic extract from Landschutz ascites cells was therefore studied by using a reaction mixture based on that described by Shigeura & Gordon (1962) . To diminish the conversion of IMP into AMP, the necessary cofactors, GTP and aspartate, were omitted. After the incubation period the cold-acid-soluble fraction was isolated and the nucleotides were converted into the free bases. The distribution of radioactivity among the purine bases was determined as described in the Materials and Methods section. Table 6 shows that mycophenolic acid strongly inhibited the incorporation oflabel into the xanthine and guanine fractions. This suggested that mycophenolic acid interfered with the formation of guanine nucleotides by inhibiting the oxidation of IMP to XMP, although the result of this experiment is open to the interpretation that the antibiotic might have inhibited the direct oxidation of hypoxanthine to xanthine by xanthine oxidase or alternatively the conversion of hypoxanthine into IMP. The next experiment, however, illustrates clearly that mycophenolic acid does in fact strongly inhibit the conversion of IMP into XMP.
Inhibition of preparations of IMP dehydrogenase by mycophenolic acid. (1) Preliminary experiments with preparations of IMP dehydrogenase from calf thymus indicated that mycophenolic acid is an extremely potent inhibitor of this enzyme. A kinetic analysis of the inhibition indicated that it was of the mixed type (Dixon & Webb, 1964) . The (2) Kinetic studies were also carried out with a preparation of IMP dehydrogenase from LS cells.
The Km for this preparation and the Ki for mycophenolic acid were calculated from the plot illustrated in Fig. 3 and gave values of 3-3 x 10-5M for Km for IMP and 3-03 x 10-8M for K,. The kinetics of inhibition again appeared to be of the mixed type.
Effect of mycophenolic acid on the accumulation of FGAR in suspensions of Landschiitz and Yoshida ascites cells and L cells induced by azaserine. A number of workers have shown that purine nucleotides, but not the corresponding free bases or nucleosides, exert feedback inhibition on the biosynthesis ofphosphoribosylamine from phosphoribosyl pyrophosphate and glutamine (Wyngaarden & Ashton, 1959; Henderson, 1963) . Since the addition of mycophenolic acid to ascites cells and L cells in vitro resulted in some increase of the radioactivity of the adenine nucleotide fraction it was decided to determine whether the antibiotic had Vol. 113 tS'W, any effect on the early stages of the biosynthesis of purine nucleotides. The antibiotic azaserine, which is an antagonist of glutamine, strongly inhibits the amination of FGAR to give formylglycine amidine ribonucleotide, and FGAR therefore accumulates in cells treated with azaserine (Moore & LePage, 1957) . Thus the extent of the accumulation of FGAR under these conditions may be used to investigate any possible inhibition of the reaction sequence leading to the formation of FGAR.
(1) Landschutz and Yoshida ascites cells. The ascitic fluid was diluted with Ca2+-free KrebsRinger phosphate medium, pH 7-4, containing 5 5mM-glucose, 1 mM-glutamine and 2 3mM-glycine. The suspensions (1 ml.) were preincubated for 30min. with or without azaserine (2,tg./ml.) or mycophenolic acid (10 or 50,ug./ml.). Sodium [14C]formate (1pc/ml.) was then added and the mixture incubated for 30min. and the uptake of radioactivity into FGAR was determined as described in the Materials and Methods section. Table 7 shows that azaserine alone produced the expected marked increase in the radioactivity of the FGAR fraction. Mycophenolic acid in the presence of azaserine caused a small decrease in the radioactivity of the FGAR. Mycophenolic acid alone, however, had no significant effect.
(2) L cells. The cells were grown in flat-sided bottles and then removed from the glass by incubation for 2min. at 37°in a solution containing: 10mM-potassium phosphate buffer, pH7.3, 0 15M-sodium chloride, 1 6mM-EDTA (disodium salt) and 0-5mg. of trypsin/ml. The (Table 7 ).
DISCUSSION
The results described in this paper indicate that mycophenolic acid is a potent inhibitor of DNA synthesis in L cells in vitro. The uptake ofthymidine and adenine into DNA is considerably more sensitive to the antibiotic than is the incorporation of adenine into RNA. Conceivably, when the concentration of guanine nucleotides is depressed by mycophenolic acid, the competition for GDP for reduction to deoxy-GDP on the one hand, and for phosphorylation to GTP on the other, might be weighted in favour of the latter pathway. A precise explanation, however, for the apparently greater sensitivity of DNA synthesis to mycophenolic acid must await further work. The possibility that mycophenolic acid has an additional, more specific, action on DNA synthesis is excluded by the completeness of the reversal of the inhibition of DNA synthesis by guanine.
Evidence has been presented showing that mycophenolic acid is a powerful inhibitor of IMP dehydrogenase. The kinetic analysis of the inhibition suggests that it is of the mixed type (Dixon & Webb, 1964) ; no evidence could be obtained of any competition with IMP despite the steric similarity between the phthalane ring of mycophenolic acid and the purine ring system. A study of the kinetics of inhibition by mycophenolic acid in relation to the second substrate, NAD+, may be useful. A detailed kinetic study of the IMP dehydrogenase of sarcoma 180 cells (Anderson & Sartorelli, 1968) has indicated that the enzymic mechanism involves an ordered sequential addition of IMP, NAD+ and K+ to the enzyme to form active enzyme-substrate complexes. It is conceivable that mycophenolic acid could interfere in some way with this orderly process or alternatively with the subsequent dissociations.
It is impossible to decide from the present results whether the decrease in the radioactivity of the FGAR accumulated in the presence of azaserine is a direct or indirect effect of mycophenolic acid. 'Whatever the explanation, a partial inhibition of an early stage of purine nucleotide synthesis induced by mycophenolic acid is likely to be of only minor importance in accounting for the inhibition of DNA synthesis by the antibiotic. With L cells, guanine is not converted into adenine nucleotides (T. J. Franklin & J. M. Cook, unpublished work) . Thus the complete reversal of mycophenolic acid-induced inhibition of DNA synthesis by guanine alone provides convincing evidence that the primary action of the antibiotic is to inhibit the conversion of IMP into XMP. Presumably the failure of xanthine to reverse the inhibition of DNA synthesis was due to the inability of L cells to convert this purine into its corresponding nucleotide (T. J. Franklin & J. M. Cook, unpublished work).
It remains to be considered whether the effects of mycophenolic acid on biosynthesis of guanine nucleotide can explain the action of the antibiotic on cell division in vitro and in vivo. With L cells the reversal of the antimitotic effect of mycophenolic acid by guanine again strongly suggests a primary effect of the antibiotic on biosynthesis of guanine nucleotides (Carter et al. 1969) .
Since mycophenolic acid evidently inhibited the conversion of IMP into XMP in Landschuitz and Yoshida ascites cells in vitro two observations with these cells require explanation: (1) the failure of the antibiotic to inhibit thymidine incorporation into DNA in suspensions of ascites cells in vitro; (2) the failure of mycophenolic acid to depress the growth of the Landschutz tumour in vivo on the one hand and the great sensitivity of the Yoshida tumour to the antibiotic in vivo on the other (Carter et al. 1969) .
The difficulties that were encountered in obtaining a sustained linear incorporation of [14C]-thymidine into the DNA of ascites cells in vitro suggest that these cells probably undergo rapid degeneration under the conditions used in this investigation. It therefore seems reasonable to suppose that the guanine nucleotide requirements for limited DNA synthesis may be met by the increased catabolism of macromolecules that would be expected in degenerating cells. Thus, although mycophenolic acid inhibits the oxidation of IMP under these conditions, this would not be reflected in an inhibition of incorporation of thymidine into DNA.
A consideration of the differential effects of mycophenolic acid in vivo on the growth of the Landschutz and Yoshida ascites tumours is of considerable practical importance. The influence of the species difference in the host animal is probably not of major significance, since a range of tumours in the mouse has been found to be sensitive to mycophenolic acid (Carter et al. 1969; Williams et al. 1968) . Leaving aside pharmacological considerations such as the distribution and penetration of mycophenolic acid into the tumours in vivo and assuming that the conversion of IMP into XMP is inhibited by the antibiotic in vivo (unpublished work indicates that this is so), the response of a tumour to mycophenolic acid will depend in part on its ability to meet its requirements for guanine nucleotides by the conversion of guanine into GMP by hypoxanthine-guanine phosphoribosyltransferase.
Thus a high rate of conversion of guanine into GMP could result in resistance to mycophenolic acid. Since 6-mercaptopurine is an effective competitive inhibitor of hypoxanthine-guanine phosphoribosyltransferase, combination of this agent with mycophenolic acid might be expected to result in a synergistic antitumour action. A dramatic synergistic effect of 6-mercaptopurine and mycophenolic acid has been demonstrated against the Ehrlich ascites tumour in mice (Carter et al. 1969 ) although neither agent alone has significant growthdepressing activity against this tumour. These results may have significance in relation to the clinical use of mycophenolic acid. 
